Wen Qi Hu
Direttore/Membro del Consiglio presso Beijing Mabworks Biotech Co., Ltd.
Posizioni attive di Wen Qi Hu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Beijing Mabworks Biotech Co., Ltd.
 Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Direttore/Membro del Consiglio | 26/03/2020 | - |
| Corporate Officer/Principal | 01/06/2017 | - |
Storia della carriera di Wen Qi Hu
Precedenti posizioni note di Wen Qi Hu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Suzhou Chuangsheng Pharmaceutical Group Co., Ltd.
 Suzhou Chuangsheng Pharmaceutical Group Co., Ltd. BiotechnologyHealth Technology MabSpace Biosciences (Suzhou) Co., Ltd. engages in the development of therapeutic antibodies for cancer and fibrotic diseases. Its products include humanized programmed death-ligand 1, humanized vascular endothelial growth factor receptors 2, humanized OX40, and humanized colony stimulating factor 1 receptor antibodies. It also offers programmed death-ligand 1 antibodies for Immunohistochemistry detection and soluble programmed death ligand 1 measurement. The company was founded by Xue Ming Qian on October 18, 2012 and is headquartered in Suzhou, China. | Corporate Officer/Principal | 01/09/2016 | 01/05/2017 |
| Crownbio Bioscience Taicang Co. Ltd. | Direttore/Membro del Consiglio | 01/02/2013 | 01/08/2016 |
| Hunan Normal University | Corporate Officer/Principal | 01/07/1986 | 01/02/1996 |
Formazione di Wen Qi Hu
| Nanjing Agricultural University | Graduate Degree |
| Hunan Agricultural University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Cina | 6 |
| 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Health Technology |
Suzhou Chuangsheng Pharmaceutical Group Co., Ltd.
Suzhou Chuangsheng Pharmaceutical Group Co., Ltd. BiotechnologyHealth Technology MabSpace Biosciences (Suzhou) Co., Ltd. engages in the development of therapeutic antibodies for cancer and fibrotic diseases. Its products include humanized programmed death-ligand 1, humanized vascular endothelial growth factor receptors 2, humanized OX40, and humanized colony stimulating factor 1 receptor antibodies. It also offers programmed death-ligand 1 antibodies for Immunohistochemistry detection and soluble programmed death ligand 1 measurement. The company was founded by Xue Ming Qian on October 18, 2012 and is headquartered in Suzhou, China. | Health Technology |
| Crownbio Bioscience Taicang Co. Ltd. |
- Borsa valori
- Insiders
- Wen Qi Hu
- Esperienza
